TDRD3 Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

TDRD3 Polyklonal Antikörper für WB, IHC, IF/ICC, IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, IP, chIP, ELISA

Konjugation

Unkonjugiert

Publikationen

1

Kat-Nr. : 13359-1-AP

Synonyme

Tudor domain-containing protein 3, tudor domain containing 3

---

Galerie der Validierungsdaten

• 

  WB analysis of HEK-293 using 13359-1-AP

  WB result of TDRD3 antibody (13359-1-AP; 1:1000; incubated at room temperature for 1.5 hours) with sh-Control and sh-TDRD3 transfected HEK-293 cells.

• 

  WB analysis of HEK-293 using 13359-1-AP

  HEK-293 cells were subjected to SDS PAGE followed by western blot with 13359-1-AP (TDRD3 antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HeLa using 13359-1-AP

  IP result of anti-TDRD3 (IP:13359-1-AP, 3ug; Detection:13359-1-AP 1:1000) with HeLa cells lysate 3800ug.

• 

  IHC staining of mouse brain using 13359-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse brain tissue slide using 13359-1-AP (TDRD3 antibody) at dilution of 1:200 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of mouse brain using 13359-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse brain tissue slide using 13359-1-AP (TDRD3 antibody) at dilution of 1:200 (under 40x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IF Staining of HeLa using 13359-1-AP

  Immunofluorescent analysis of HeLa cells using 13359-1-AP (TDRD3 antibody) at dilution of 1:25 and Rhodamine-Goat anti-Rabbit IgG.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: HEK-293-Zellen
• Erfolgreiche IP: HeLa-Zellen
• Erfolgreiche Detektion in IHC: Maushirngewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
• Erfolgreiche Detektion in IF/ICC: HeLa-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:2000
• Immunpräzipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunhistochemie (IHC): IHC : 1:50-1:500
• Immunfluoreszenz (IF)/ICC: IF/ICC : 1:10-1:100

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• ChIP: See 1 publications below

Produktinformation

13359-1-AP bindet in WB, IHC, IF/ICC, IP, chIP, ELISA TDRD3 und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• In Publikationen genannte Reaktivität: human
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: TDRD3 fusion protein Ag4174
• Vollständiger Name: tudor domain containing 3
• Berechnetes Molekulargewicht: 651 aa, 73 kDa
• Beobachtetes Molekulargewicht: 73 kDa, 83 kDa
• GenBank-Zugangsnummer: BC030514
• Gene symbol: TDRD3
• Gene ID (NCBI): 81550
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TDRD3 (Tudor domain-containing protein 3) contains tudor domain which is an approximately 60-amino acid structure motif. TDRD3 functions as a scaffolding protein that specifically recognizes and binds dimethylarginine-containing proteins. TDRD3 is a transcriptional coactivator that promotes transcription by binding methylarginine marks on histone tails. TDRD3 also possesses an oligosaccharide/nucleotide binding fold and an ubiquitin associated domain capable of binding tetra-ubiquitin, and it is reported to associate with polyribosomes in HeLa cells.

Publikationen

Species	Application	Title
human	chIP	Theranostics; A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.; Authors - Bing-Ling Peng